Cardiovascular disease epidemiology with specific areas related to heart failure, genetic epidemiology, pharmacogenomics, and environmental health. I am also interested in translation-oriented methods to assess the burden of cardiovascular diseases in diverse populations.
Avery CL, Loehr LR, Baggett C, Chang PP, Kucharska-Newton AM, Matsushita K, Rosamond WD, Heiss G. (2012) The Population Burden of Heart Failure Attributable to Modifiable Risk Factors: The ARIC (Atherosclerosis Risk in Communities) Study. J Am Coll Cardiol: vol.60(17), p.1640-6.
Avery CL, He QC, North KE, Ambite JL, Boerwinkle E, Fornage M, Hindorff LA, Kooperberg C, Meigs JB, Pankow JS, Pendergrass SA, Psaty BM, Ritchie MD, Rotter JI, Taylor KD, Wilkens LR, Heiss G, Lin DY (2011) A Phenomics-Based Strategy Identifies Loci on APOC1, BRAP, and PLCG1 Associated with Metabolic Syndrome Phenotype Domains. PLoS Genetics: vol.7(10), p.e1002322.
Avery CL, Mills KT, Williams R, McGraw KA, Poole C, Smith RL, Whitsel EA (2010) Estimating error in using ambient PM2.5 concentrations as proxies for personal exposures: a review. Epidemiology: vol.21(2), p.215-223.
We've been pointing out some of the ridiculous media hype on Ebola over the last 10 days or so. Share this CDC info (below) #UNC #Gillings with your friends and other social channels. Only hope of mollifying the hype is to spread these facts (over and over and over again).View on Facebook